ABSI vs DLHC

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 22, 2026

ABSI

37.3
AI Score
VS
DLHC Wins

DLHC

52.3
AI Score

Investment Advisor Scores

ABSI

37score
Recommendation
EXTENDED

DLHC

52score
Recommendation
STRONG BUY

AI Analyst Insights

Detailed Metrics Comparison

Metric ABSI DLHC Winner
Forward P/E 0 17.452 Tie
PEG Ratio 0 1.1263 Tie
Revenue Growth -46.4% -46.9% ABSI
Earnings Growth 0.0% -75.0% ABSI
Tradestie Score 37.3/100 52.3/100 DLHC
Profit Margin 0.0% -8.5% ABSI
Beta 1.00 1.00 Tie
AI Recommendation EXTENDED STRONG BUY DLHC

Relative Price Performance (Last 90 Days)

ABSI 1M: +18.3% · 3M: +87.6% DLHC 1M: -10.7% · 3M: -18.4%

Current Technical Phase

ABSI

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (14.3% over 20 days), RSI 57

RSI (14): 56.6 · Price: $9.55

DLHC

Markdown
Sell / avoid

Price below a falling SMA50 (slope -5.4%), weak momentum, RSI 34

RSI (14): 33.6 · Price: $4.53

Fundamentals Snapshot

Metric ABSI DLHC
Market Cap
Forward P/E -14.1 -6.6
Trailing P/E
Revenue (TTM)
Revenue Growth -0.5% -0.5%
Gross Margin -54.0% 0.2%
Operating Margin -107.4% -0.1%
EPS -0.73 -1.49
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, DLHC is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.